Clinical Trials Browser

Phase 2 × Liver Cirrhosis × Erlotinib Hydrochloride × Clear all

NCT04172779 2026-05-01

ECHO-B

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis